Repligen Corporation (NasdaqGS:RGEN) entered into an agreement to acquire Bio-Flex Solutions, L.L.C. / Newton T & M Corp on November 29, 2021. The consideration is paid in cash. The transaction is immediately accretive to adjusted EPS 2022.

Repligen Corporation (NasdaqGS:RGEN) completed the acquisition of Bio-Flex Solutions, L.L.C. / Newton T & M Corp for $31.8 million on December 16, 2021. The purchase price of $31.8 million includes $3 million deposited into an escrow against which the Company may make claims for indemnification.